Oral ivermectin for a scabies outbreak in a long-term care facility: potential value in preventing COVID-19 and associated mortality

Br J Dermatol. 2021 Jun;184(6):1207-1209. doi: 10.1111/bjd.19821. Epub 2021 Mar 1.

C Bernigaud^{1

2}, D Guillemot^{3

4

5}, A Ahmed-Belkacem⁶, L Grimaldi-Bensouda^{3

4}, A Lespine⁷, F Berry⁶, L Softic⁶, C Chenost⁸, G Do-Pham⁹, B Giraudeau¹⁰, S Fourati^{1

6}, O Chosidow^{1

2}

¹ APHP, Hôpital Henri-Mondor, Université Paris-Est, Créteil, France.
² Research Group Dynamic, Université Paris-Est Créteil, Créteil, France.
³ Université Paris-Saclay, Montigny-Le-Bretonneux, France.
⁴ APHP, Paris-Saclay, Le Kremlin-Bicêtre, France.
⁵ Institut Pasteur, Epidemiology and Modelling of Antibiotic Evasion, Paris, France.
⁶ Inserm U955, Université de Santé, Paris-Est, Créteil, France.
⁷ INTHERES, Université de Toulouse, Toulouse, France.
⁸ Long-Term Care Facility Chief Medical Officer, Seine-et-Marne, France.
⁹ Service de Médecine Interne, Centre Intercommunal de Créteil, Créteil, France.
¹⁰ UMR SPHERE Inserm U1246, Université de Tours, Tours, France.

No abstract available

Publication types